Multiple myeloma (MM) is a uniformly fatal disease. Current therapies provide short-term palliation. Consequently, new approaches to the treatment of MM are needed. The applicant has recently observed that a novel nucleoside analog, 8-Chloro-Adenosine (8Cl-AD), is very effective in promoting programmed cell death in a number of MM cell lines that are resistant to traditional chemotherapeutic agents. Encouraged by initial in vitro results, the NCI has awarded the laboratory a RAID grant for large scale production of 8Cl-AD and to collaboratively perform in vivo analysis. Nucleosides with closely related structures exhibit cellular metabolic characteristics and action mechanisms that vary widely. Most impressively, it is clear that nucleoside analogs with closely related structures, that share metabolic pathways, and inhabit similar target enzymes, still exhibit a diverse spectrum of anticancer activity in human tumor types in the clinic. Hence, understanding the metabolism and actions of any drug is requisite to optimizing its clinical utility. Here, the mechanism of action for 8Cl-AD will be elucidated. Preliminary data support that this purine analog preferentially inhibits RNA synthesis. The proposed investigation will address the cellular metabolism and actions of 8Cl-AD using HPLC to measure the accumulation and elimination of 8Cl-AD nucleotides. The applicant will determine if 8Cl-AD has an effect on ribonucleotide reductase activity and he will also explore the inhibitory potency of 8Cl-AD on RNA synthesis. Using chemical and enzymatic methods, he will synthesize DNA and RNA polymers that contain 8Cl-AD to determine the biological impact on DNA and RNA biosynthesis. He will examine key steps in the induction of apoptosis including mitochondrial injury and caspase activation to determine if those steps are regulated by 8Cl-AD. He anticipates that these studies will allow us to maximize the therapeutic potential of this agent against MM and related malignancies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA085915-01
Application #
6091299
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Forry, Suzanne L
Project Start
2000-08-22
Project End
2004-07-31
Budget Start
2000-08-22
Budget End
2001-07-31
Support Year
1
Fiscal Year
2000
Total Cost
$281,015
Indirect Cost
Name
Northwestern University at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Phillip, Cornel Joseph; Zaman, Shadia; Shentu, Shujun et al. (2013) Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines. J Hematol Oncol 6:92
McBrayer, Samuel K; Yarrington, Michael; Qian, Jun et al. (2012) Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms. PLoS One 7:e41455
Tessel, Michael A; Benham, Ashley L; Krett, Nancy L et al. (2011) Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma. Horm Cancer 2:182-9
Rovedo, Mark A; Krett, Nancy L; Rosen, Steven T (2011) Inhibition of glycogen synthase kinase-3 increases the cytotoxicity of enzastaurin. J Invest Dermatol 131:1442-9
Zhang, Honghao; Gogada, Raghu; Yadav, Neelu et al. (2011) Defective molecular timer in the absence of nucleotides leads to inefficient caspase activation. PLoS One 6:e16379
Dennison, Jennifer B; Ayres, Mary L; Kaluarachchi, Kumar et al. (2010) Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels. J Biol Chem 285:8022-30
Chen, Lisa S; Du-Cuny, Lei; Vethantham, Vasupradha et al. (2010) Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues. Biochem Pharmacol 79:669-77
Dennison, Jennifer B; Shanmugam, Mala; Ayres, Mary L et al. (2010) 8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma. Blood 116:5622-30
Frey, Jennifer Ann; Gandhi, Varsha (2010) 8-Amino-adenosine inhibits multiple mechanisms of transcription. Mol Cancer Ther 9:236-45
Stellrecht, Christine M; Ayres, Mary; Arya, Rishi et al. (2010) A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels. Breast Cancer Res Treat 121:355-64

Showing the most recent 10 out of 36 publications